Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Reviews

Drug-induced liver injury: present and future

Ki Tae Suk, Dong Joon Kim

Clin Mol Hepatol. 2012;18(3):249-257. Published online September 25, 2012

Crossref 104

DOI: https://doi.org/10.3350/cmh.2012.18.3.249

Changes of guidelines diagnosing hepatocellular carcinoma during the last ten-year period

Do Seon Song, Si Hyun Bae

Clin Mol Hepatol. 2012;18(3):258-267. Published online September 25, 2012

Crossref 65

DOI: https://doi.org/10.3350/cmh.2012.18.3.258

Editorial

Impact of ribavirin dose reduction during treatment in chronic hepatitis C genotype 1 patients

Woo Jin Chung

Clin Mol Hepatol. 2012;18(3):268-271. Published online September 25, 2012

Crossref 1

DOI: https://doi.org/10.3350/cmh.2012.18.3.268

Original Articles

A reduced dose of ribavirin does not influence the virologic response during pegylated interferon alpha-2b and ribavirin combination therapy in patients with genotype 1 chronic hepatitis C

Byung Chul You, Young Seok Kim, Hun il Kim, Se Hun Kim, Seung Sik Park, Yu Ri Seo, Sang Gyune Kim, Se Whan Lee, Hong Soo Kim, Soung Won Jeong, Jae Young Jang, Boo Sung Kim

Clin Mol Hepatol. 2012;18(3):272-278. Published online September 25, 2012

Crossref 1

DOI: https://doi.org/10.3350/cmh.2012.18.3.272

Enhanced A-FABP expression in visceral fat: potential contributor to the progression of NASH

Min Yong Yoon, Jun Mo Sung, Chang Seok Song, Won Young Lee, Eun Jung Rhee, Jun Ho Shin, Chang Hak Yoo, Seoung Wan Chae, Ja Yeon Kim, Wook Jin, Yong Kyun Cho

Clin Mol Hepatol. 2012;18(3):279-286. Published online September 25, 2012

Crossref 11

DOI: https://doi.org/10.3350/cmh.2012.18.3.279

Cyclooxygenase-2 and vascular endothelial growth factor in chronic hepatitis, cirrhosis and hepatocellular carcinoma

Soon Ha Kwon, Soung Won Jeong, Jae Young Jang, Ji Eun Lee, Sae Hwan Lee, Sang Gyune Kim, Young Seok Kim, Young Deok Cho, Hong Soo Kim, Boo Sung Kim, So-Young Jin

Clin Mol Hepatol. 2012;18(3):287-294. Published online September 25, 2012

Crossref 12

DOI: https://doi.org/10.3350/cmh.2012.18.3.287

Association between apolipoprotein E genotype, chronic liver disease, and hepatitis B virus

Seun Joo Ahn, Dong Kyu Kim, Soon Sun Kim, Chang Bum Bae, Hyo Jung Cho, Han Gyeol Kim, Young Jip Kim, Joo Ho Lee, Hyo Jin Lee, Mi Yeon Lee, Kee Bum Kim, Jin Hee Cho, Sung Won Cho, Jae Youn Cheong

Clin Mol Hepatol. 2012;18(3):295-301. Published online September 25, 2012

Crossref 17

DOI: https://doi.org/10.3350/cmh.2012.18.3.295

Thrombocytopenia represents a risk for deterioration of liver function after radiofrequency ablation in patients with hepatocellular carcinoma

Hyun Seok Lee, Soo Young Park, Sung Kook Kim, Young Oh Kweon, Won Young Tak, Chang Min Cho, Seong Woo Jeon, Min Kyu Jung, Hyun Gu Park, Dong Wook Lee, So Young Choi

Clin Mol Hepatol. 2012;18(3):302-308. Published online September 25, 2012

Crossref 12

DOI: https://doi.org/10.3350/cmh.2012.18.3.302

Type and cause of liver disease in Korea: single-center experience, 2005-2010

Sang Soo Lee, Young-Sang Byoun, Sook-Hyang Jeong, Yeo Myung Kim, Ho Gil, Bo-Young Min, Mun Hyuk Seong, Eun Sun Jang, Jin-Wook Kim

Clin Mol Hepatol. 2012;18(3):309-315. Published online September 25, 2012

Crossref 50

DOI: https://doi.org/10.3350/cmh.2012.18.3.309

Case Reports

Spinal cord injury after conducting transcatheter arterial chemoembolization for costal metastasis of hepatocellular carcinoma

Sang Jung Park, Chang Ha Kim, Jin Dong Kim, Soon Ho Um, Sun Young Yim, Min Ho Seo, Dae In Lee, Jun Hyuk Kang, Bora Keum, Yong Sik Kim

Clin Mol Hepatol. 2012;18(3):316-320. Published online September 25, 2012

Crossref 6

DOI: https://doi.org/10.3350/cmh.2012.18.3.316

A case of necrotizing pancreatitis subsequent to transcatheter arterial chemoembolization in a patient with hepatocellular carcinoma

Song-I Bae, Jong Eun Yeon, Jong Mee Lee, Ji Hoon Kim, Hyun Jung Lee, Sun Jae Lee, Sang Jun Suh, Eileen L. Yoon, Hae Rim Kim, Kwan Soo Byun, Tae-Seok Seo

Clin Mol Hepatol. 2012;18(3):321-325. Published online September 25, 2012

Crossref 16

DOI: https://doi.org/10.3350/cmh.2012.18.3.321

Liver Pathology

Adenosquamous carcinoma of the liver

Shin Young Park, Eun Jung Cha, Woo Sung Moon

Clin Mol Hepatol. 2012;18(3):326-329. Published online September 25, 2012

Crossref 7

DOI: https://doi.org/10.3350/cmh.2012.18.3.326

Liver Imaging

Hepatic angiomyolipoma with minimal fat, mimicking hepatocellular carcinoma

So Jung Lee, So Yeon Kim, Kyoung Won Kim, Yong Moon Shin, Hyoung Jung Kim, Jong Seok Lee, Sun A Kim

Clin Mol Hepatol. 2012;18(3):330-335. Published online September 25, 2012

Crossref 14

DOI: https://doi.org/10.3350/cmh.2012.18.3.330

Viewed By 4873	MAFLD: How is it different from NAFLD?
Viewed By 4821	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 4665	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4401	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 4341	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 214	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 155	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 133	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 117	MAFLD: How is it different from NAFLD?
Cited By 94	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Previous issues